Skip to main content

Together we are beating cancer

Donate now

Cancer News

Treatment

Showing 12 out of 1231 results

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples. We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

by Nick Peel | Analysis | 15 March 2016

15 March 2016

A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug. A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.

by Emma Smith | Analysis | 14 March 2016

14 March 2016

An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment. An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment.

by Cancer Research UK | News | 14 March 2016

14 March 2016

Breast cancer screening

UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference

by Aine McCarthy | Analysis | 11 March 2016

11 March 2016

Human T cell.

Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system. Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.

by In collaboration with PA Media Group | News | 11 March 2016

11 March 2016

A drug combination – of lapatinib and trastuzumab – before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days. A drug combination – of lapatinib and trastuzumab – before surgery shrinks and may even destroy tumours in women with HER2 positive disease within 11 days.

by Cancer Research UK | News | 10 March 2016

10 March 2016

A Cancer Research UK clinical trial that showed focused radiotherapy after treatment has less long-term side effects than standard whole breast radiotherapy. A Cancer Research UK clinical trial that showed focused radiotherapy after treatment has less long-term side effects than standard whole breast radiotherapy.

by Cancer Research UK | News | 9 March 2016

9 March 2016